Another Wrinkle For Baxter's Infusion Biz? Sigma Recalls Spectrum Pumps
This article was originally published in The Gray Sheet
Executive Summary
Medina, N.Y.-based Sigma is recalling nearly a quarter of its Spectrum infusion pumps because the units may fail suddenly, resulting in potential over-infusion or other flow problems.
You may also be interested in...
FDA Hits Baxter With Two Warning Letters In Four Weeks
The warning letters cite quality system regulation violations related to the firm’s infusion pumps, including inadequate corrective and preventive actions related to complaints of over-infusion and device bladder ruptures.
FDA Recall Order Gives Baxter Two Years To Replace Infusion Pumps
Baxter has until July 14, 2012, to ensure that all Colleague infusion pumps on the U.S. market have been recalled and destroyed, and that customers have received a refund or a replacement pump, according to a final recall order from FDA
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.